Suppr超能文献

使用长期性别确认激素治疗的跨性别女性和跨性别男性的骨折风险:一项全国性队列研究。

Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort Study.

作者信息

Wiepjes Chantal M, de Blok Christel Jm, Staphorsius Annemieke S, Nota Nienke M, Vlot Mariska C, de Jongh Renate T, den Heijer Martin

机构信息

Department of Endocrinology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.

Center of Expertise on Gender Dysphoria, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.

出版信息

J Bone Miner Res. 2020 Jan;35(1):64-70. doi: 10.1002/jbmr.3862. Epub 2019 Oct 7.

Abstract

Concerns about bone health in transgender people using gender-affirming hormonal treatment (HT) exist, but the fracture risk is not known. In this nationwide cohort study, we aimed to compare the fracture incidence in transgender people using long-term HT with an age-matched reference population. All adult transgender people who started HT before 2016 at our gender-identity clinic were included and were linked to a random population-based sample of 5 age-matched reference men and 5 age-matched reference women per person. Fracture incidence was determined using diagnoses from visits to hospital emergency rooms nationwide between 2013 and 2015. A total of 1089 trans women aged <50 years (mean 38 ± 9 years) and 934 trans women aged ≥50 years (mean 60 ± 8 years) using HT for median 8 (interquartile range [IQR] 3-16) and 19 (IQR 11-29) years, respectively, were included. A total of 2.4% of the trans women aged <50 years had a fracture, whereas 3.0% of the age-matched reference men (odds ratio [OR] = 0.78, 95% confidence interval [CI] 0.51-1.19) and 1.6% of the age-matched reference women (OR = 1.49, 95% CI 0.96-2.32) experienced a fracture. In trans women aged ≥50 years, 4.4% experienced a fracture compared with 2.4% of the age-matched reference men (OR = 1.90, 95% CI 1.32-2.74) and 4.2% of the age-matched reference women (OR = 1.05, 95% CI 0.75-1.49). A total of 1036 trans men (40 ± 14 years) using HT for median 9 (IQR 2-22) years were included. Fractures occurred in 1.7% of the trans men, 3.0% of the age-matched reference men (OR = 0.57, 95% CI 0.35-0.94), and 2.2% of the age-matched reference women (OR = 0.79, 95% CI 0.48-1.30). In conclusion, fracture risk was higher in older trans women compared with age-matched reference men. In young trans women, fracture risk tended to be increased compared with age-matched reference women. Fracture risk was not increased in young trans men. © 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.

摘要

对于接受性别肯定激素治疗(HT)的跨性别者的骨骼健康存在担忧,但骨折风险尚不清楚。在这项全国性队列研究中,我们旨在比较长期接受HT的跨性别者与年龄匹配的参照人群的骨折发生率。纳入了所有在2016年前于我们的性别认同诊所开始接受HT的成年跨性别者,并将其与每人5名年龄匹配的参照男性和5名年龄匹配的参照女性的基于人群的随机样本相联系。使用2013年至2015年间全国医院急诊室就诊的诊断结果来确定骨折发生率。共有1089名年龄<50岁(平均38±9岁)的跨性别女性和934名年龄≥50岁(平均60±8岁)的跨性别女性纳入研究,她们接受HT的时间中位数分别为8年(四分位间距[IQR] 3 - 16)和19年(IQR 11 - 29)。年龄<50岁的跨性别女性中共有2.4%发生了骨折,而年龄匹配的参照男性中有3.0%(比值比[OR] = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc9/7003754/5e43613593a0/JBMR-35-64-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验